Cite
HARVARD Citation
Luen, S. et al. (2019). Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple-negative breast cancer patients after neoadjuvant chemotherapy. Annals of oncology. pp. 236-242. [Online].